The publication of the Synuclein-One Study in JAMA, Journal of the American Medical Association continues to draw media attention. Last week, Christopher Gibbons, MD, lead author of the study and Professor of Neurology at Harvard Medical School was interviewed on CBS News. Dr. Gibbons explained why clinicians can’t always rely on symptoms alone to diagnose neurodegenerative disorders like #ParkinsonsDisease and #DementiaWithLewyBodies, how the Syn-One Test® can help provide a diagnosis several years before symptoms develop, and what that could mean for patients when new treatments are developed. Watch the interview. https://lnkd.in/g3hFWAyu CND Life Sciences Rick Morello Todd Levine #msa #neurology
This is great news! Maybe doctors will start using this great resource.
Very impressive!
Rare Disease KOL, Educator & Advocate for people with Multiple System Atrophy & Atypical Parkinson’s
7moGreat to hear that the Syn-One Test is getting more attention!